Evidence map›Paper›PMID 37857997›Full record

ReviewVirchows Archiv : an international journal of pathology2024

Practical guidelines of the EOTTD for pathological and genetic diagnosis of hydatidiform moles.

Carla Bartosch, Alfons Nadal, Ana C Braga, Angela Salerno, Anne-Laure Rougemont, Anne-Sophie Van Rompuy, Brendan Fitzgerald, Caroline Joyce, Fabienne Allias, Geoffrey J Maher and 12 more

Erratum issuedAbstract readReview
PubMed Publisher
In one paragraph

Review in Virchows Archiv : an international journal of pathology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Morphology combined withJournal of clinical pathology · 2025
    Article
  5. Diagnosis of hydatidiform moles usingInternational journal of reproductive biomedicine · 2024
    Article
  6. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors at 18 institutions in 11 countries.

Carla BartoschDepartment of Pathology, Cancer Biology & Epigenetics Group, Research Center of IPO Porto (CI-IPOP) / RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC) and Centro Hospitalar Universitário S. João, Rua Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal. carla.bartosch@ipoporto.min-saude.pt.ORCID http://orcid.org/0000-0003-0646-7667
Alfons NadalDepartment of Pathology, Clínic Barcelona, Department of Basic Clinical Practice, Universitat de Barcelona, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.
Ana C BragaDepartment of Pathology, University Hospital Centre of São João (CHUSJ) / Faculty of Medicine - University of Porto (FMUP) / School of Health (ESS) - Polytechnic Institute of Porto (P. PORTO), Alameda Prof. Hernâni Monteiro, 4200-319, Porto, Portugal.
Angela SalernoAnatomia Patologica, Ospedale Maggiore AUSL Bologna, Bologna, Italy.
Anne-Laure RougemontDivision of Clinical Pathology, Geneva University Hospital, Geneva, Switzerland.
Anne-Sophie Van RompuyDepartment of Pathology, University Hospitals Leuven, Louvain, Belgium.
Brendan FitzgeraldDepartment of Pathology, Cork University Hospital, Cork, Ireland.
Caroline JoyceDepartment of Clinical Biochemistry, Cork University Hospital, Ireland/ Pregnancy Loss Research Group, Department of Obstetrics & Gynaecology, University College Cork, Cork, Ireland.
Fabienne AlliasDepartment of Pathology, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre Bénite, France.
Geoffrey J MaherTrophoblastic Tumour Screening & Treatment Centre, Imperial College NHS Trust, Charing Cross Hospital, Fulham Palace Road, London, W6 8RF, UK.
Gitta TurowskiDepartment of Pathology, Oslo University Hospital, INNPATH Tirolkliniken, Innsbruck, Austria.
Jean-Christophe TilleDivision of Clinical Pathology, Geneva University Hospital, Geneva, Switzerland.
Kinan Drak AlsibaiDepartment of Pathology and Center of Biological Resources (CRB Amazonie), Cayenne Hospital Center Andrée Rosemon, 97306, Cayenne, France.
Koen Van de VijverDepartment of Pathology, Ghent University Hospital, Ghent, Belgium.
Lesley McMahonScottish Hydatidiform Mole Follow-Up Service, Ninewells Hospital and Medical School, Dundee, Scotland.
Lone SundeDepartment of Clinical Genetics, Aalborg University Hospital, Denmark/Department of Biomedicine, Aarhus University, Aalborg, Aarhus, Denmark.
Michal PyzlakDepartment of Pathology, Institute of Mother and Child, Warsaw, Poland.
Paul DowneyDepartment of Pathology, National Maternity Hospital, Dublin, D02YH21, Ireland.
Sandra WessmanDepartment of Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden.
Sophie PatrierDepartment of Pathology, Rouen University Hospital, Rouen, France.
Baljeet Kaur *Department of Pathology, North West London Pathology, Imperial College NHS Trust, Fulham Palace Road, London, W6 8RF, UK.
Rosemary Fisher *Department of Surgery and Cancer, Imperial College London, Charing Cross Hospital. Fulham Palace Road, London, W6 8RF, UK.
Charing Cross Hospital · GBUniversity Hospital of Geneva · CHAarhus University · DKConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESCork University Hospital · IEGhent University Hospital · BEHospices Civils de Lyon · FRInstituto Português de Oncologia Francisco Gentil · PTKarolinska University Hospital · SEKU Leuven · BENational Maternity Hospital · IENinewells Hospital · GBNorth West London Pathology · GBOspedale Maggiore · ITTirol Kliniken · ATUniversidade do Porto · PTUniversité de Rouen Normandie · FRUniversity College Cork · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hydatidiform moles are rare and thus most pathologists and geneticists have little experience with their diagnosis. It is important to promptly and correctly identify hydatidiform moles given that they are premalignant disorders associated with a risk of persistent gestational trophoblastic disease and gestational trophoblastic neoplasia. Improvement in diagnosis can be achieved with uniformization of diagnostic criteria and establishment of algorithms. To this aim, the Pathology and Genetics Working Party of the European Organisation for Treatment of Trophoblastic Diseases has developed guidelines that describe the pathological criteria and ancillary techniques that can be used in the differential diagnosis of hydatidiform moles. These guidelines are based on the best available evidence in the literature, professional experience and consensus of the experts' group involved in its development.

Indexed as

Gestational Trophoblastic DiseaseHydatidiform MoleUterine NeoplasmsDiagnosis, DifferentialFemaleHumansPregnancyDiagnosisGeneticsGenotypingGuidelinesHydatidiform molesPathology

Identifiers

PMID37857997
OpenAlexW4387772086

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.